Guanlan Xu

1.7k total citations
27 papers, 1.3k citations indexed

About

Guanlan Xu is a scholar working on Molecular Biology, Surgery and Cell Biology. According to data from OpenAlex, Guanlan Xu has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Surgery and 10 papers in Cell Biology. Recurrent topics in Guanlan Xu's work include Pancreatic function and diabetes (11 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and MicroRNA in disease regulation (5 papers). Guanlan Xu is often cited by papers focused on Pancreatic function and diabetes (11 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and MicroRNA in disease regulation (5 papers). Guanlan Xu collaborates with scholars based in United States, Canada and China. Guanlan Xu's co-authors include Anath Shalev, Junqin Chen, Jing Gu, Truman Grayson, Lance A. Thielen, Peng Li, Kyung-Hee Hong, Tiffany Grimes, Fernando Ovalle and Praveen Sethupathy and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Guanlan Xu

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guanlan Xu United States 17 669 603 339 308 267 27 1.3k
Lorenzo Pasquali Spain 14 833 1.2× 652 1.1× 576 1.7× 297 1.0× 129 0.5× 25 1.6k
Wissal El-Assaad Canada 15 985 1.5× 856 1.4× 274 0.8× 555 1.8× 212 0.8× 17 1.9k
Shigeru Yatoh Japan 25 793 1.2× 705 1.2× 266 0.8× 421 1.4× 263 1.0× 44 1.7k
Alpana Bhattacharjee Canada 19 607 0.9× 634 1.1× 200 0.6× 309 1.0× 208 0.8× 24 1.4k
Patrick Linsel‐Nitschke Germany 17 755 1.1× 887 1.5× 170 0.5× 257 0.8× 183 0.7× 24 1.7k
Sarah Hummasti United States 8 564 0.8× 577 1.0× 180 0.5× 200 0.6× 99 0.4× 8 1.3k
Lara P. Fernández Spain 28 595 0.9× 651 1.1× 166 0.5× 243 0.8× 306 1.1× 51 1.7k
Kazuaki Miyake Japan 17 1.0k 1.6× 514 0.9× 278 0.8× 304 1.0× 97 0.4× 31 1.6k
Marc C. Daniels United States 18 926 1.4× 493 0.8× 124 0.4× 213 0.7× 139 0.5× 21 1.3k
Bernadette Neve France 17 1.3k 2.0× 740 1.2× 255 0.8× 316 1.0× 335 1.3× 30 2.0k

Countries citing papers authored by Guanlan Xu

Since Specialization
Citations

This map shows the geographic impact of Guanlan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanlan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanlan Xu more than expected).

Fields of papers citing papers by Guanlan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanlan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanlan Xu. The network helps show where Guanlan Xu may publish in the future.

Co-authorship network of co-authors of Guanlan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Guanlan Xu. A scholar is included among the top collaborators of Guanlan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanlan Xu. Guanlan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Jing, et al.. (2025). Oral TIX100 protects against obesity‐associated glucose intolerance and diet‐induced adiposity. Diabetes Obesity and Metabolism. 27(4). 2223–2231. 1 indexed citations
2.
Xu, Guanlan, Tiffany Grimes, Truman Grayson, et al.. (2022). Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes. Nature Communications. 13(1). 1159–1159. 49 indexed citations
3.
Vispoel, Walter P., et al.. (2022). Expanding bifactor models of psychological traits to account for multiple sources of measurement error.. Psychological Assessment. 34(12). 1093–1111. 10 indexed citations
4.
Xu, Guanlan, Lance A. Thielen, Junqin Chen, et al.. (2019). Serum miR-204 is an early biomarker of type 1 diabetes-associated pancreatic beta-cell loss. American Journal of Physiology-Endocrinology and Metabolism. 317(4). E723–E730. 35 indexed citations
5.
Ovalle, Fernando, Tiffany Grimes, Guanlan Xu, et al.. (2018). Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nature Medicine. 24(8). 1108–1112. 171 indexed citations
6.
Thielen, Lance A., et al.. (2018). Novel Small Molecule TXNIP Inhibitor Protects Against Diabetes. Diabetes. 67(Supplement_1). 3 indexed citations
7.
Xu, Guanlan, et al.. (2018). GDF15 Is Induced by T1D-Associated Cytokines and ER Stress and Promotes Beta-Cell Apoptosis. Diabetes. 67(Supplement_1). 2 indexed citations
8.
Hong, Kyung-Hee, Guanlan Xu, Truman Grayson, & Anath Shalev. (2016). Cytokines Regulate β-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways. Journal of Biological Chemistry. 291(16). 8428–8439. 53 indexed citations
9.
Xu, Guanlan, Junqin Chen, Jing Gu, Truman Grayson, & Anath Shalev. (2016). miR-204 Targets PERK and Regulates UPR Signaling and β-Cell Apoptosis. Molecular Endocrinology. 30(8). 917–924. 51 indexed citations
10.
Gu, Jing, Junqin Chen, Guanlan Xu, & Anath Shalev. (2016). Islet ChREBP-β is increased in diabetes and controls ChREBP-α and glucose-induced gene expression via a negative feedback loop. Molecular Metabolism. 5(12). 1208–1215. 28 indexed citations
11.
Chen, Junqin, Jing Gu, Guanlan Xu, & Anath Shalev. (2014). Thioredoxin-Interacting Protein Stimulates Its Own Expression via a Positive Feedback Loop. Molecular Endocrinology. 28(5). 674–680. 35 indexed citations
12.
Xu, Guanlan, et al.. (2014). MicroRNA-200 Is Induced by Thioredoxin-interacting Protein and Regulates Zeb1 Protein Signaling and Beta Cell Apoptosis. Journal of Biological Chemistry. 289(52). 36275–36283. 87 indexed citations
13.
Gu, Jing, Clara Westwell‐Roper, Junqin Chen, et al.. (2014). Thioredoxin-interacting Protein Promotes Islet Amyloid Polypeptide Expression through miR-124a and FoxA2. Journal of Biological Chemistry. 289(17). 11807–11815. 54 indexed citations
14.
Xu, Guanlan, Junqin Chen, Jing Gu, & Anath Shalev. (2013). Thioredoxin-interacting protein regulates insulin transcription through microRNA-204. Nature Medicine. 19(9). 1141–1146. 227 indexed citations
15.
16.
Cha‐Molstad, Hyunjoo, Guanlan Xu, Junqin Chen, et al.. (2012). Calcium Channel Blockers Act through Nuclear Factor Y to Control Transcription of Key Cardiac Genes. Molecular Pharmacology. 82(3). 541–549. 19 indexed citations
17.
Xu, Guanlan, Junqin Chen, Jing Gu, & Anath Shalev. (2012). Preventing β-Cell Loss and Diabetes With Calcium Channel Blockers. Diabetes. 61(4). 848–856. 198 indexed citations
18.
Chen, Li, Jingyao Zhou, Huilei Xu, Guanlan Xu, & Jinglun Xue. (2009). Identification and developmental expression of Dec2 in zebrafish. Fish Physiology and Biochemistry. 36(3). 667–675. 4 indexed citations
19.
Xu, Guanlan, Caihong Zhou, Ling Tian, et al.. (2009). ΦC31 integrase interacts with TTRAP and inhibits NFκB activation. Molecular Biology Reports. 37(6). 2809–2816. 13 indexed citations
20.
Chen, Jinzhong, Chaoneng Ji, Guanlan Xu, et al.. (2006). DAXX interacts with phage ΦC31 integrase and inhibits recombination. Nucleic Acids Research. 34(21). 6298–6304. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026